{"rows":[{"id":5870,"title":"Level of preparedness to use psilocybin among individuals seeking psychedelic risk reduction: a retrospective study of a pilot psychiatric consultation service","authors":"Harrison Harland V., Gaillard Mizan, Cook Ryan R., Sarparast Aryan, Levander Ximena A.","journal":"Frontiers in Public Health","publication_date":"2026-09-16","publication_year":2026,"doi":"10.3389/fpubh.2026.1921031","pubmed_id":null,"openalex_id":"https://openalex.org/W7213236102","source_url":"https://doi.org/10.3389/fpubh.2026.1921031","substance_tags":"psilocybin","topic_tags":"Review Article,Safety,Adverse Events","study_type":"Review Article","source_name":"Crossref","publication_status":"published","date_added":"2026-08-20 01:20:38","last_checked":"2026-09-23 01:20:29","bibtex":null,"source_record_id":"DOI:10.3389/fpubh.2026.1921031","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3389/fpubh.2026.1921031","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.3389/fpubh.2026.1921031","source_url":"https://doi.org/10.3389/fpubh.2026.1921031","doi":"10.3389/fpubh.2026.1921031","pmid":"","publication_date":"2026-09-16","importer_version":"2.1.3","text_redistributed":false}},{"id":5737,"title":"Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosis","authors":"Tsang Vivian WL, Kryskow Pamela, Watler Crosbie, Allard Pearl, Dames Shannon","journal":"Frontiers in Public Health","publication_date":"2026-07-20","publication_year":2026,"doi":"10.3389/fpubh.2026.1767215","pubmed_id":"42548601","openalex_id":"https://openalex.org/W7169758970","source_url":"https://doi.org/10.3389/fpubh.2026.1767215","substance_tags":"psilocybin","topic_tags":"End-of-Life Distress,Resilience,Observational Study,Cancer Patients,Safety","study_type":"Observational Study","source_name":"Crossref","publication_status":"published","date_added":"2026-07-21 01:20:20","last_checked":"2026-08-09 08:28:46","bibtex":null,"source_record_id":"PMID:42548601","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3389/fpubh.2026.1767215","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42548601","source_url":"https://doi.org/10.3389/fpubh.2026.1767215","doi":"10.3389/fpubh.2026.1767215","pmid":"42548601","publication_date":"2026-07-20","importer_version":"2.1.3","text_redistributed":false}},{"id":1924,"title":"Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico","authors":"Leeman Lawrence, Armstrong Maya, Menashi Dara, Nayo-Washington Hanifa, Marseille Elliot, Herrera Janus, Romero Crystal, Page-Reeves Janet","journal":"Frontiers in Public Health","publication_date":"2026-06-17","publication_year":2026,"doi":"10.3389/fpubh.2026.1845943","pubmed_id":"42395285","openalex_id":"https://openalex.org/W7165032301","source_url":"https://doi.org/10.3389/fpubh.2026.1845943","substance_tags":"psilocybin","topic_tags":"PTSD,Aging,Clinical Trial,Veterans,Healthcare Workers,Safety","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:49:23","last_checked":"2026-08-09 08:28:46","bibtex":null,"source_record_id":"PMID:42395285","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3389/fpubh.2026.1845943","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42395285","source_url":"https://doi.org/10.3389/fpubh.2026.1845943","doi":"10.3389/fpubh.2026.1845943","pmid":"42395285","publication_date":"2026-06-17","importer_version":"2.1.3","text_redistributed":false}},{"id":172,"title":"A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience","authors":"Back Anthony L., McGregor Bonnie A., Thorn Leslie L., Harvey Kalin, Blom Dianna, Callan George, Guy John, Kumar Sameet, Hershberg Rob, Layer Melissa, Levin Jackie, Myers Susanna, Perez Juliana, Salmonson Kathy, Thompson Peter, Whinney Joseph","journal":"Frontiers in Public Health","publication_date":"2026-04-14","publication_year":2026,"doi":"10.3389/fpubh.2026.1810904","pubmed_id":"42058096","openalex_id":"https://openalex.org/W7154396122","source_url":"https://doi.org/10.3389/fpubh.2026.1810904","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Headache / Migraine,Mystical Experience,Clinical Trial,Cancer Patients,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:48","bibtex":null,"source_record_id":"PMID:42058096","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.3389/fpubh.2026.1810904","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42058096","source_url":"https://doi.org/10.3389/fpubh.2026.1810904","doi":"10.3389/fpubh.2026.1810904","pmid":"42058096","publication_date":"2026-04-14","importer_version":"2.1.3","text_redistributed":false}}],"total":4,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Frontiers in Public Health","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}